OTCPK:MEPD.F

Stock Analysis Report

Executive Summary

MediPal Holdings Corporation engages in the wholesale of prescription and OTC pharmaceuticals, cosmetics, daily necessities, animal health products, food processing raw materials, food additives, medical equipment and supplies, clinical diagnostics, etc.

Snowflake

Fundamentals

Excellent balance sheet and fair value.

Share Price & News

How has MediPal Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

OTCPK:MEPD.F

0.1%

US Healthcare

0.8%

US Market


1 Year Return

n/a

OTCPK:MEPD.F

-8.4%

US Healthcare

1.9%

US Market

No trading data on MEPD.F.

No trading data on MEPD.F.


Share holder returns

MEPD.FIndustryMarket
7 Day0%0.1%0.8%
30 Day0%-1.4%3.4%
90 Day0%-0.7%2.1%
1 Yearn/a-7.0%-8.4%4.2%1.9%
3 Yearn/a30.6%25.3%46.7%37.2%
5 Yearn/a64.9%55.1%62.3%44.5%

Price Volatility Vs. Market

How volatile is MediPal Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is MediPal Holdings undervalued based on future cash flows and its price relative to the stock market?

14.46x

Price to Earnings (PE) ratio


Intrinsic Value Based on Future Cash Flows

MediPal Holdings's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).

MediPal Holdings's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).


Price Based on Earnings

MediPal Holdings is good value based on earnings compared to the US Healthcare industry average.

MediPal Holdings is good value based on earnings compared to the United States of America market.


Price Based on Expected Growth

MediPal Holdings is poor value based on expected growth next year.


Price Based on Value of Assets

MediPal Holdings is good value based on assets compared to the US Healthcare industry average.


Next Steps

Future Growth

How is MediPal Holdings expected to perform in the next 1 to 3 years based on estimates from 4 analysts?

5.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

MediPal Holdings's revenue is expected to grow by 1.7% yearly, however this is not considered high growth (20% yearly).

MediPal Holdings's earnings are expected to grow by 5.4% yearly, however this is not considered high growth (20% yearly).

MediPal Holdings's revenue growth is positive but not above the United States of America market average.

MediPal Holdings's earnings growth is positive but not above the United States of America market average.

MediPal Holdings's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

MediPal Holdings is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).


Next Steps

Past Performance

How has MediPal Holdings performed over the past 5 years?

9.2%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

MediPal Holdings's year on year earnings growth rate has been positive over the past 5 years.

MediPal Holdings's 1-year earnings growth is negative, it can't be compared to the 5-year average.

MediPal Holdings's 1-year earnings growth is negative, it can't be compared to the US Healthcare industry average.


Return on Equity

MediPal Holdings has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).


Return on Assets

MediPal Holdings used its assets less efficiently than the US Healthcare industry average last year based on Return on Assets.


Return on Capital Employed

MediPal Holdings's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).


Next Steps

Financial Health

How is MediPal Holdings's financial position?


Financial Position Analysis

MediPal Holdings is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

MediPal Holdings's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

MediPal Holdings's level of debt (9.5%) compared to net worth is satisfactory (less than 40%).

The level of debt compared to net worth has increased over the past 5 years (8.6% vs 9.5% today).

Debt is well covered by operating cash flow (113.6%, greater than 20% of total debt).

MediPal Holdings earns more interest than it pays, coverage of interest payments is not a concern.


Balance Sheet

High level of physical assets or inventory.

Debt is covered by short term assets, assets are 20.8x debt.


Next Steps

Dividend

What is MediPal Holdings's current dividend yield, its reliability and sustainability?

1.77%

Expected Dividend Yield


Dividend Yield and Payments Analysis

MediPal Holdings's pays a higher dividend yield than the bottom 25% of dividend payers in United States of America (1.51%).

MediPal Holdings's dividend is below the markets top 25% of dividend payers in United States of America (3.93%).

Dividends per share have been volatile in the past 10 years (annual drop of over 20%).

Dividends per share have increased over the past 10 years.


Current Payout to Shareholders

Dividends paid are well covered by earnings (4x coverage).


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of MediPal Holdings's salary, the management and board of directors tenure and is there insider trading?

7.0yrs

Average management tenure


CEO

Shuichi Watanabe (67yo)

7.3yrs

Tenure

0

Mr. Shuichi Watanabe has been Chief Executive Officer and President at MediPal Holdings Corporation since April 2012. Mr. Watanabe served as the Chief Executive Officer and President of Mediceo Corporation ...


Management Age and Tenure

7.0yrs

Average Tenure

The average tenure for the MediPal Holdings management team is over 5 years, this suggests they are a seasoned and experienced team.


Board Age and Tenure

7.1yrs

Average Tenure

65yo

Average Age

The tenure for the MediPal Holdings board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Shuichi Watanabe (67yo)

    CEO, President & Representative Director

    • Tenure: 7.3yrs
  • Toshihide Yoda (56yo)

    Senior MD

    • Tenure: 9.6yrs
  • Hideaki Takemura

    Managing Executive Officer & Deputy GM of Business Development Department

    • Tenure: 0yrs
  • Yasuhiro Choufuku

    Senior MD & Director

    • Tenure: 12.6yrs
  • Masanori Kawahara

    Managing Executive Officer

    • Tenure: 0yrs
  • Masaaki Shimizu

    Managing Executive Officer & Manager of Secretarial Office - Administration Division

    • Tenure: 0yrs
  • Kenichi Takase

    Executive Officer & Manager of Corporate Planning Department - Administration Division

    • Tenure: 0yrs
  • Yuji Sakon

    MD, GM of Administration Division & Director

    • Tenure: 7.6yrs
  • Shinjiro Watanabe

    GM of Information Systems Mgmt. Div

    • Tenure: 6.6yrs
  • Kimio Nakamura

    Executive Officer & Deputy GM of Administration Division

    • Tenure: 0yrs

Board Members

  • Shuichi Watanabe (67yo)

    CEO, President & Representative Director

    • Tenure: 7.3yrs
  • Toshihide Yoda (56yo)

    Senior MD

    • Tenure: 9.6yrs
  • Takuro Hasegawa

    Director

    • Tenure: 15.6yrs
  • Yasuhiro Choufuku

    Senior MD & Director

    • Tenure: 12.6yrs
  • Kuniko Shoji

    Outside Director

    • Tenure: 1.6yrs
  • Toshio Asano (67yo)

    Outside Director

    • Tenure: 2.6yrs
  • Kunio Ninomiya (63yo)

    Director

    • Tenure: 3.2yrs
  • Yuji Sakon

    MD, GM of Administration Division & Director

    • Tenure: 7.6yrs
  • Shinjiro Watanabe

    GM of Information Systems Mgmt. Div

    • Tenure: 6.6yrs
  • Mitsuko Kagami

    Outside Director

    • Tenure: 5.6yrs

Company Information

MediPal Holdings Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: MediPal Holdings Corporation
  • Ticker: MEPD.F
  • Exchange: OTCPK
  • Founded: 1898
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Market Cap: JP¥493.204b
  • Listing Market Cap: JP¥4.659b
  • Shares outstanding: 222.46m
  • Website: https://www.medipal.co.jp

Number of Employees


Location

  • MediPal Holdings Corporation
  • 2-7-15, Yaesu
  • Chuo-ku
  • Tokyo
  • 104-8461
  • Japan

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
7459TSE (The Tokyo Stock Exchange)YesCommon StockJPJPYSep 1995
MEPD.FOTCPK (Pink Sheets LLC)YesCommon StockUSUSDSep 1995
MAHL.YOTCPK (Pink Sheets LLC)UNSPONSORED ADRUSUSDNov 2008

Biography

MediPal Holdings Corporation engages in the wholesale of prescription and OTC pharmaceuticals, cosmetics, daily necessities, animal health products, food processing raw materials, food additives, medical e ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/08/29 00:20
End of Day Share Price2019/05/31 00:00
Earnings2019/06/30
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.